- Home
- IINN vs ITRM Comparison
IINN vs ITRM Comparison
Compare IINN & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IINN
- ITRM
- Stock Information
- Founded
- IINN 2018
- ITRM 2015
- Country
- IINN Israel
- ITRM Ireland
- Employees
- IINN N/A
- ITRM N/A
- Industry
- IINN Medical/Dental Instruments
- ITRM Biotechnology: Pharmaceutical Preparations
- Sector
- IINN Health Care
- ITRM Health Care
- Exchange
- IINN Nasdaq
- ITRM Nasdaq
- Market Cap
- IINN 40.4M
- ITRM 40.0M
- IPO Year
- IINN 2021
- ITRM 2018
- Fundamental
- Price
- IINN $1.16
- ITRM $0.74
- Analyst Decision
- IINN Strong Buy
- ITRM Strong Buy
- Analyst Count
- IINN 1
- ITRM 1
- Target Price
- IINN $2.00
- ITRM $9.00
- AVG Volume (30 Days)
- IINN 270.6K
- ITRM 841.8K
- Earning Date
- IINN 10-01-2025
- ITRM 11-13-2025
- Dividend Yield
- IINN N/A
- ITRM N/A
- EPS Growth
- IINN N/A
- ITRM N/A
- EPS
- IINN N/A
- ITRM N/A
- Revenue
- IINN $289,000.00
- ITRM N/A
- Revenue This Year
- IINN N/A
- ITRM N/A
- Revenue Next Year
- IINN $3,100.00
- ITRM $482.25
- P/E Ratio
- IINN N/A
- ITRM N/A
- Revenue Growth
- IINN N/A
- ITRM N/A
- 52 Week Low
- IINN $0.40
- ITRM $0.61
- 52 Week High
- IINN $1.65
- ITRM $3.02
- Technical
- Relative Strength Index (RSI)
- IINN 45.32
- ITRM 52.39
- Support Level
- IINN $1.14
- ITRM $0.70
- Resistance Level
- IINN $1.28
- ITRM $0.83
- Average True Range (ATR)
- IINN 0.07
- ITRM 0.05
- MACD
- IINN -0.01
- ITRM 0.01
- Stochastic Oscillator
- IINN 16.67
- ITRM 47.65
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.